About this trial
The focus of this study is to perform a preliminary assessment of the efficacy of the BurtVision system. While the Burt robotic-arm assists the patient's upper-limb in their movements, BurtVision will allow the patient to perform unimanual and bimanual activities while leveraging augmented reality games. The investigators will compare clinical outcomes when the BurtVisions ystem is used for training solely relying on unimanual tasks vs. when it is used for training relying on both unimanual and bimanual tasks.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female, 18-80 years old;
Unilateral ischemic or hemorrhagic stroke at least 6 months and no more than 5 years prior to study enrollment;
Upper extremity hemiparesis as characterized by initial scores on upper limb subtest of the Fugl-Meyer Assessment (FMA-UE) between 12 and 40;
Some active pro-supination range of motion;
Disqualifiers
Undergoing upper-limb rehabilitation therapy during the period of the study.
Severe spasticity (defined as a Modified Ashworth scale score of 3 or more) that would prevent safe use of the robotic system;
Visual impairments as assessed by the NIH Stroke Scale Visual Field subscale (only subjects with no visual loss will participate in the study); or hemispatial neglect that would impair the subject's ability to play the interactive games (as assessed with the line bisection test);
Severe proprioceptive deficits that impair the ability to process haptic or visual feedback, as assessed by physical examination during screening;
Trial design
Parallel
Treatments tested in this trial
Burt
Device18 one-hour sessions of unimanual upper-limb tasks during robot-assisted training with the Burt.
Burt + BurtVision
Device18 one-hour sessions of combination of unimanual and bimanual upper-limb tasks during robot-assisted training with the BurtVision.
Treatment groups
Trial outcomes
Primary outcomes
Motor Activity Log- Amount of Use
Self-reported measures of upper extremity activity performance in daily life (amount of use)
Secondary outcomes
Fugl-Meyer Assessment, Upper-Extremity portion
Assessment of the severity of upper-limb motor impairments
Wolf Motor Function Test
Assessment of arm functional limitations
Stroke Impact Scale
Self-reported measure of quality of life after stroke
Motor Activity Log- Quality of Use
Self-reported measures of upper extremity activity performance in daily life (quality of use)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: